Stifel Nicolaus Has Lowered Expectations for Bolt Biotherapeutics (NASDAQ:BOLT) Stock Price
Bolt Biotherapeutics (NASDAQ:BOLT – Get Free Report) had its price objective lowered by stock analysts at Stifel Nicolaus from $1.50 to $1.25 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. Stifel Nicolaus’ price target would suggest a potential upside of 184.09% […]
Bolt Biotherapeutics (NASDAQ:BOLT – Get Free Report) had its price objective lowered by stock analysts at Stifel Nicolaus from $1.50 to $1.25 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. Stifel Nicolaus’ price target would suggest a potential upside of 184.09% […]
